Navigation Links
Insmed Announces First Quarter 2011 Financial Results
Date:5/10/2011

nce of $104.9 million, which will continue to drive our development of ARIKACE®."

Financial Results:For the first quarter of 2011, Insmed posted a net loss attributable to common stockholders of $16.1 million, or $0.85 per share – basic and diluted, compared to net income of 0.1 million, or $0.01 per share – basic and diluted, for the three months ended March 31, 2010.  The net loss attributable to common stockholders in 2011 includes the conversion of the Series B Conditional Convertible Preferred Stock, and a non-cash charge for the beneficial conversion feature of the Series B Preferred Stock in the amount of $9.2 million.  When issuing debt or equity securities that are convertible into common stock at a discount from the fair value of the common stock at the date the debt or equity financing is committed, a company is required to record a beneficial conversion feature ("BCF") charge in accordance with Accounting Standards Codification 470-20.  This BCF of $9.2 million reduced net income available to holders of our common shares and, in turn, reduced our earnings per common share on a basic and diluted basis, by $0.48.  The charge represents the $1.00 difference between the conversion price of the preferred stock of $7.10 per share and its carrying value of $6.10 per share.  The carrying value of the preferred stock was based on its fair value at issuance, which was estimated using the common stock price reduced for a lack of marketability between the issuance date and the anticipated date of conversion.

Revenues were $1.6 million, as compared to $1.9 million for the quarter ended March 31, 2010.  The reduction in revenue was primarily attributable to $0.6 million in lower cost recovery from our IPLEX™ Expanded Access Program in Europe, which was partially offset by $0.3 million in licensing fees received during the most recent quarter.  The reduced IPLEX™ cost recovery was due to t
'/>"/>

SOURCE Insmed Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Insmed to Host 2011 First Quarter Earnings Conference Call
2. Insmed Announces European Medicines Agency Acceptance of Its Pediatric Investigation Plan for ARIKACE™ in the Cystic Fibrosis Pseudomonas Indication
3. One-for-10 Reverse Stock Split of Insmed Common Stock Becomes Effective
4. Insmed Shareholders Approve Conversion of Series B Conditional Convertible Preferred Stock and Reverse Stock Split
5. Insmed to Host Fourth Quarter and 2010 Year-End Earnings Conference Call
6. NASDAQ Grants Insmed Incorporated 180-Day Extension to Regain Compliance with Minimum Bid Price Rule
7. Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2010
8. Insmed to Host Third Quarter 2010 Conference Call
9. Insmed Initiates Clinical Study for Follow-on Biologic Version of Neulasta(R)
10. Insmed CEO to Present at Congressional Briefing on Follow-On Biologics
11. Insmed Announces First Human Bioequivalence Data for a Follow-on Biologic by a U.S. Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... 31, 2015  SCILEX Pharmaceuticals, Inc., a company engaged ... the treatment of pain, today announced that ITOCHU CHEMICAL ... a member of ITOCHU Corporation ( Tokyo ... sogo shosha (general trading companies) in Japan ...  ICF has worked closely with SCILEX as an advisor ...
(Date:3/31/2015)... -- SynCardia Systems, Inc. has received FDA approval to conduct ... effective use of its 50cc SynCardia temporary Total Artificial ... The FDA approval will allow SynCardia to launch the ... Patients enrolled in this study will receive the 50cc ... donor heart transplant. (Caution-In the United States, the ...
(Date:3/31/2015)... 31, 2015 /CNW/ - T-Bird Pharma Inc. (TSXV:TPI) ("T-Bird" or ... quality medical marijuana products and a licensed producer ("LP") ... Regulations ( Canada ) ("MMPR"), is pleased ... Corporation of the District of Saanich ... premises which now allows for commercial distribution of medical ...
Breaking Medicine Technology:SCILEX Pharmaceuticals Announces Strategic Investment By ITOCHU CHEMICAL FRONTIER Corporation 2FDA Approves Investigational Study for New Smaller SynCardia Total Artificial Heart 2FDA Approves Investigational Study for New Smaller SynCardia Total Artificial Heart 3FDA Approves Investigational Study for New Smaller SynCardia Total Artificial Heart 4T-Bird Pharma Inc. Announces Final Municipal Rezoning Approval 2T-Bird Pharma Inc. Announces Final Municipal Rezoning Approval 3
... Group, Inc. (OTCBB: BONU), and Barnabas Health in ... collaborative research and revenue sharing agreement.  The parties ... detergent cleaner, 90-second disinfectant and 20-minute sterilant. In ... rapid cleaning and sterilization of surgical instruments, scopes, ...
... Jan. 24, 2012 Life Spine, a medical device company ... treatment of spinal disorders, announced record revenues and double digit ... The record revenue reflects a series of ... been an outstanding year for Life Spine. Our rapid growth ...
Cached Medicine Technology:BioNeutral and Barnabas Health to Collaborate for Surgical Instrument Sterilization 2BioNeutral and Barnabas Health to Collaborate for Surgical Instrument Sterilization 3
(Date:3/31/2015)... 2015 The Walk a Mile Project, as ... , just kicked off their 3rd research sequence. The ... “ Substantial Equivalence was and is a massive component ... Director at Change The World Films. “We started our ... GMOs even entered our food supply, just to get a ...
(Date:3/31/2015)... NJ (PRWEB) March 31, 2015 At Summit ... to all patients in a calm and caring manner. , ... the diagnosis and surgical treatment of breast cancer. They ... area but from all over the world. Their doctors ... local publications. , The seeds for Summit Breast Care were ...
(Date:3/31/2015)... TX (PRWEB) March 31, 2015 One of the ... be a visit to Mount Kilauea on the big island. ... few places where you can see molten lava slowly oozing at ... on earth. , One place you would never expect ... the flat, arid terrain of Mission, Texas -- until now. , ...
(Date:3/31/2015)... 2015 Greenfield Senior continues to ... LLC ("Care") a seniors housing-focused real estate investment ... announces today, their acquisition of six senior housing ... million. Concurrent with the acquisition, Care will master ... Living ("Greenfield"). Pursuant to the lease, Care will ...
(Date:3/31/2015)... 2015 The New Jersey Chapter ... (ACHCA) elected two administrators from Windsor Healthcare Communities, ... in New Jersey, to two key leadership roles ... Robert Reyes, administrator for Abingdon Care & Rehabilitation ... Yael Herman, administrator of Canterbury Care & Rehabilitation ...
Breaking Medicine News(10 mins):Health News:The Walk a Mile Project Launches New Research Sequence on Substantial Equivalence of GMOs 2Health News:Summit Breast Care is Celebrating Four Years as "NJ Top Docs" 2Health News:Rare Volcano Constructed inside Gold’s Gym in Mission, Texas 2Health News:Rare Volcano Constructed inside Gold’s Gym in Mission, Texas 3Health News:Greenfield Senior Living Inc. Enters Lease Transaction with Care Investment Trust LLC 2Health News:Greenfield Senior Living Inc. Enters Lease Transaction with Care Investment Trust LLC 3Health News:Abingdon Care & Rehabilitation Center’s Administrator Elected President of N.J. Chapter of the American College of Health Care Administrators 2
... Ont., July 11, 2011More patients are tested and ... to screening for the bone disease, a new study ... the clinic actually provides bone mineral density (BMD) testing ... rather than just referring fracture patients elsewhere. Researchers ...
... , FRIDAY, July 8 (HealthDay News) -- Many dieters feel ... that the pounds somehow return after that. New research ... help people lose weight don,t overlap much with those that ... Penn State University. The team investigated whether two distinct ...
... has found that almost all patients with high-grade noninvasive bladder ... guidelines. Published early online in CANCER , a peer-reviewed ... efforts are needed to identify and overcome barriers to providing ... bladder cancer has up to a 70 percent chance of ...
... Researchers at the Wellman Center for Photomedicine at ... version of the intravascular imaging technology optical coherence ... features of coronary artery disease. In a ... publication, the investigators describe how microOCT which ...
... 9 (HealthDay News) -- Too few parents understand their role in ... suggests. Each year, more than 10,000 people in the United ... parents and children shower before they go to a water park ... infection, but there seems to be a lack of awareness about ...
... group of patients who may have increased difficulty for surgical ... because a teenager or young adult has a pelvis that ... presented at the annual meeting of the American Orthopaedic Society ... "The conclusion from this study is that you should ...
Cached Medicine News:Health News:New study highlights what works in osteoporosis treatment 2Health News: Losing Weight, Keeping It Off Can Be Two Different Worlds 2Health News: Losing Weight, Keeping It Off Can Be Two Different Worlds 3Health News:Bladder cancer patients rarely receive recommended care 2Health News:High-resolution imaging technology reveals cellular details of coronary arteries 2Health News:Parents Can Help Stop Spread of Water Park Illnesses 2Health News:Study identifies patients who should not undergo surgery for a snapping hip tendon 2Health News:Study identifies patients who should not undergo surgery for a snapping hip tendon 3
World's first commercially available vacuum assisted biopsy device for MRI....
... stereotactic, ultrasound and MRI-guided vacuum assisted breast ... Use the patented, FDA-cleared ATEC system for ... advanced method of breast biopsy. Its compassionate ... who trust YOU.,9 Gauge Handpieces: Useful for ...
... can perform stereotactic, ultrasound and MRI-guided vacuum ... your office. Use the patented, FDA-cleared ATEC ... more clinically advanced method of breast biopsy. ... the women who trust YOU.,9 Gauge Handpieces: ...
12" Penrose drains...
Medicine Products: